Trial Outcomes & Findings for A Rehabilitation Tool to Determine Patient's Stay in Hospital After Joint Replacement (NCT NCT03776357)
NCT ID: NCT03776357
Last Updated: 2022-06-30
Results Overview
Recruitment status
TERMINATED
Study phase
NA
Target enrollment
9 participants
Primary outcome timeframe
Up to 2 days
Results posted on
2022-06-30
Participant Flow
Participant milestones
| Measure |
Experimental
Participants utilize FDA cleared Virtual Exercise Rehabilitation Assistant (VERA™) platform during pre-operative visit to obtain functional outcome scores.
|
|---|---|
|
Overall Study
STARTED
|
9
|
|
Overall Study
COMPLETED
|
6
|
|
Overall Study
NOT COMPLETED
|
3
|
Reasons for withdrawal
| Measure |
Experimental
Participants utilize FDA cleared Virtual Exercise Rehabilitation Assistant (VERA™) platform during pre-operative visit to obtain functional outcome scores.
|
|---|---|
|
Overall Study
Lost to Follow-up
|
3
|
Baseline Characteristics
A Rehabilitation Tool to Determine Patient's Stay in Hospital After Joint Replacement
Baseline characteristics by cohort
| Measure |
Experimental
n=9 Participants
Participants utilize the VERA platform during pre-operative visit to obtain functional outcome scores.
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
9 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
5 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
4 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
2 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
7 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
1 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
1 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
3 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
4 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
9 Participants
n=5 Participants
|
|
Gait aide use
Nothing
|
9 Participants
n=5 Participants
|
|
Gait aide use
Cane
|
0 Participants
n=5 Participants
|
|
Gait aide use
crutch
|
0 Participants
n=5 Participants
|
|
Gait aide use
walker
|
0 Participants
n=5 Participants
|
|
Range of motion ( maximum degrees)
Extension
|
0.6 degrees
STANDARD_DEVIATION 1.7 • n=5 Participants
|
|
Range of motion ( maximum degrees)
Flexion
|
117.8 degrees
STANDARD_DEVIATION 5.7 • n=5 Participants
|
PRIMARY outcome
Timeframe: Up to 2 daysOutcome measures
| Measure |
Experimental
n=9 Participants
Participants utilize the VERA platform during pre-operative visit to obtain functional outcome scores.
|
|---|---|
|
Length of Stay in Hospital Through Discharge
|
2 days
Interval 2.0 to 2.0
|
SECONDARY outcome
Timeframe: 3 months post operative visitThe gait aide use ranges in the order of decreasing performance as Nothing \> Cane \> crutch \> walker.
Outcome measures
| Measure |
Experimental
n=9 Participants
Participants utilize the VERA platform during pre-operative visit to obtain functional outcome scores.
|
|---|---|
|
Number of Participants Requiring Gait Aid Use
None ( no gait aide)
|
9 Participants
|
|
Number of Participants Requiring Gait Aid Use
Cane
|
0 Participants
|
|
Number of Participants Requiring Gait Aid Use
Crutch
|
0 Participants
|
|
Number of Participants Requiring Gait Aid Use
Walker
|
0 Participants
|
SECONDARY outcome
Timeframe: 3 months post operative visitTo assess the effectiveness of the device by calculating knee society score (KSS) after surgery. The scale ranges from 0-100 with grading as Score 80-100 - Excellent Score 70-79 - Good Score 60-69 - Fair Score below 60 - Poor
Outcome measures
| Measure |
Experimental
n=9 Participants
Participants utilize the VERA platform during pre-operative visit to obtain functional outcome scores.
|
|---|---|
|
Knee Society Score (KSS)
Excellent (80-100)
|
6 Participants
|
|
Knee Society Score (KSS)
Good (70-79)
|
0 Participants
|
|
Knee Society Score (KSS)
Fair (60-69)
|
2 Participants
|
|
Knee Society Score (KSS)
Poor ( below 60)
|
1 Participants
|
SECONDARY outcome
Timeframe: 3 months post operative visitTo assess the effectiveness of the device by calculating range of motion (maximum degrees)
Outcome measures
| Measure |
Experimental
n=9 Participants
Participants utilize the VERA platform during pre-operative visit to obtain functional outcome scores.
|
|---|---|
|
Knee Range of Motion
extension
|
1.1 degrees
Standard Deviation 2.2
|
|
Knee Range of Motion
flexion
|
107.8 degrees
Standard Deviation 17.5
|
Adverse Events
Experimental
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place